Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005201-19-000121
Filing Date
2019-11-07
Accepted
2019-11-07 08:39:04
Documents
96
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a9302019-form10xq.htm 10-Q 1616925
2 EXHIBIT 4.1 exhibit41-thirdsupplementa.htm EX-4.1 630639
3 EXHIBIT 10.1 exhibit101-firstamendmentt.htm EX-10.1 45205
4 EXHIBIT 10.2 exhibit102-formofamendment.htm EX-10.2 29626
5 EXHIBIT 31.1 exhibit311-3q2019.htm EX-31.1 12996
6 EXHIBIT 31.2 exhibit312-3q2019.htm EX-31.2 12864
7 EXHIBIT 32.1 exhibit321-3q2019.htm EX-32.1 6989
8 EXHIBIT 32.2 exhibit322-3q2019.htm EX-32.2 7033
  Complete submission text file 0001005201-19-000121.txt   9710305

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT asrt-20190930.xml EX-101.INS 2023707
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20190930.xsd EX-101.SCH 69109
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20190930_cal.xml EX-101.CAL 106923
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20190930_def.xml EX-101.DEF 356738
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20190930_lab.xml EX-101.LAB 827248
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20190930_pre.xml EX-101.PRE 514283
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

EIN.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13111 | Film No.: 191198277
SIC: 2834 Pharmaceutical Preparations